Nexalin Technology (NXL) Operating Income (2021 - 2026)
Nexalin Technology's quarterly Operating Income came in at -$2.1 million in Q1 2026, down 5.4% year-on-year from -$2.2 million in Q1 2025, and up 12.15% quarter-over-quarter from -$2.4 million in Q4 2025.
Nexalin Technology has reported Operating Income for 6 years, with the latest figure at -$2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 5.4% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$8.5 million (up 2.22% YoY), and the FY2025 full-year result was -$8.4 million, down 8.2% from the prior year.
- Operating Income for Q1 2026 stood at -$2.1 million, up from -$2.4 million in the prior quarter.
- The five-year high for Operating Income was -$293194.0 in Q3 2022, with the low at -$2.9 million in Q4 2024.
- Average Operating Income over 5 years is -$1.5 million, with a median of -$1.6 million recorded in 2025.
- Year-over-year, Operating Income soared 83.67% in 2022 and tumbled 723.87% in 2023.
- Tracing NXL's Operating Income over 5 years: stood at -$719617.0 in 2022, then slumped by 125.74% to -$1.6 million in 2023, then slumped by 77.0% to -$2.9 million in 2024, then advanced by 16.08% to -$2.4 million in 2025, then advanced by 12.15% to -$2.1 million in 2026.
- The last three Operating Income figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.12 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -2.88 Mn |
| Sep 30, 2024 | -2.51 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -2.42 Mn |
| Jun 30, 2023 | -876,860.00 |
| Mar 31, 2023 | -779,426.00 |
| Dec 31, 2022 | -719,617.00 |
| Sep 30, 2022 | -293,194.00 |
| Jun 30, 2022 | -445,103.00 |
| Mar 31, 2022 | -375,117.00 |
| Dec 31, 2021 | -577,489.00 |
| Sep 30, 2021 | -1.80 Mn |